ReviewThe Biochemical journal2026
Protein kinase C theta: evolution, regulation, and function.
Review in The Biochemical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Protein kinase C (PKC) is a family of serine/threonine kinases whose nine members play central roles in signal transduction, regulating key cellular processes such as proliferation, migration, differentiation, and apoptosis. PKC theta (θ) is a member of the diacylglycerol-regulated novel-d PKC subfamily and differentiates itself from other family members in its selective expression in hematopoietic cells, where it is essential for T cell activation, differentiation, and survival. Given its pivotal role in immune signaling, dysregulated PKCθ has been implicated in inflammatory and autoimmune diseases, as well as cancer. However, unlike the extensively studied Ca2+-regulated conventional PKC isozymes, the mechanisms of PKCθ and its roles in both health and disease remain relatively unexplored. In this review, we examine the evolution of PKCθ, its domain structure and lifecycle, its role in immune signaling, and its relevance in disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.